Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis
Cancers · 11.10.2023 · 15 (20) · 4929
DOI: 10.3390/cancers15204929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 11.10.2023. Verfasst von Anna Lena Hohneck und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidel…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
This retrospective analysis investigated the influence of integrative therapies in addition to palliative chemotherapy in patients with advanced pancreatic cancer, treated at a single institution specialized in integrative oncology between January 2015 and December 2019. In total, 206 consecutive patients were included in the study, whereof 142 patients (68.9%) received palliative chemotherapy (gemcitabine/nab-paclitaxel 33.8%; FOLFIRINOX 35.9%; gemcitabine 30.3%) while the remainder were treated with best supportive and integrative care. Integrative therapies were used in 117 of 142 patients (82.4%) in addition to conventional chemotherapy, whereby mistletoe was used in 117 patients (82.4%) and hyperthermia in 74 patients (52.1%). A total of 107/142 patients (86.3%) died during the observation period, whereby survival times differed significantly depending on the additional use of integrative mistletoe or hyperthermia: chemotherapy alone 8.6 months (95% CI 4.7–15.4), chemotherapy and only mistletoe therapy 11.2 months (95% CI 7.1–14.2), or a combination of chemotherapy with mistletoe and hyperthermia 18.9 months (95% CI 15.2–24.5). While the survival times observed for patients with advanced pancreatic cancer receiving chemotherapy alone are consistent with pivotal phase-III studies and German registry data, we found significantly improved survival using additional mistletoe and/or hyperthermia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, 69117 Heidelberg, Germany.
- European Center for AngioScience (ECAS), German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, 68167 Mannheim, Germany.
- Onkologische Praxis Kaiserslautern, 67655 Kaiserslautern, Germany.
- Department of Haematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, 69117 Heidelberg, Germany.
- Klinik Öschelbronn, 75223 Oeschelbronn, Germany.
- AnthroMed Öschelbronn, Centrum für Integrative Medizin, 75223 Oeschelbronn, Germany.
ORCID-Profile: Anna Lena Hohneck, Ralf-Dieter Hofheinz
Zitieren
APA
Hohneck, A. L., Sadikaj, L., Heinemann, L., Schroeder, M., Riess, H., Gerhards, A., Burkholder, I., Heckel-Reusser, S., Gottfried, J., & Hofheinz, R. D. (2023). Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis. Cancers, 15(20), 4929. https://doi.org/10.3390/cancers15204929
Vancouver
Hohneck AL, Sadikaj L, Heinemann L, Schroeder M, Riess H, Gerhards A, et al. Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis. Cancers. 2023;15(20):4929. doi:10.3390/cancers15204929
BibTeX
@article{Hohneck2023,
author = {Hohneck, Anna Lena and Sadikaj, Largsi and Heinemann, Lara and Schroeder, Maik and Riess, Hartmut and Gerhards, Annette and Burkholder, Iris and Heckel-Reusser, Stefan and Gottfried, Julia and Hofheinz, Ralf-Dieter},
title = {Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {4929},
doi = {10.3390/cancers15204929}
}
EUVIMED